Is 19q13.11 Microdeletion Syndrome hereditary?

19q13.11 Microdeletion Syndrome is a genetic condition caused by the loss of a specific segment of genetic material on chromosome 19, but it is rarely inherited from a parent. In the vast majority of cases, 19q13.11 Microdeletion Syndrome occurs as a de novo (spontaneous) event during the formation of reproductive cells or early embryonic development, meaning parents typically do not carry the deletion.

Is 19q13.11 Microdeletion Syndrome hereditary?

While 19q13.11 Microdeletion Syndrome is a genetic condition, it is not usually "hereditary" in the sense of being passed down through generations. Most individuals with 19q13.11 Microdeletion Syndrome have the deletion as a new, de novo mutation. Because the deletion is spontaneous, the chance of parents having another child with this syndrome is generally very low, though parental chromosomal testing is always recommended to rule out balanced translocations.

How is 19q13.11 Microdeletion Syndrome diagnosed?

Diagnosis of 19q13.11 Microdeletion Syndrome is confirmed through chromosomal microarray analysis (CMA), which detects the loss of genetic material at the 19q13.11 locus. Clinical geneticists may recommend testing for the following reasons:

• Developmental delays or intellectual disability observed in a child.


• Characteristic physical features or growth patterns associated with the syndrome.


• Parental testing to confirm if the deletion is de novo or inherited.


• Prenatal diagnosis via amniocentesis or chorionic villus sampling (CVS) for future pregnancies.

What is the role of genetic counseling?

Genetic counseling is essential for families navigating a diagnosis of 19q13.11 Microdeletion Syndrome. A counselor helps families understand the recurrence risk, provides emotional support, and assists in navigating reproductive options. For the 19 community members currently on DiseaseMaps.org, genetic counseling has been a vital resource for understanding the specific implications of their genetic report.

Next steps

• Consult with a board-certified clinical geneticist to review microarray results.


• Request parental chromosomal testing to determine if the deletion is de novo.


• Connect with the 19q13.11 Microdeletion Syndrome community on DiseaseMaps.org to share experiences and insights.


• Discuss future family planning and prenatal testing options with a reproductive genetic counselor.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): 19q13.11 microdeletion syndrome overview.


• Orphanet: Rare disease database entry for chromosome 19q13.11 deletion.


• Online Mendelian Inheritance in Man (OMIM): Database of genes and genetic disorders.


• PubMed: Peer-reviewed clinical literature regarding 19q13.11 microdeletion syndrome genotype-phenotype correlations.